387 related articles for article (PubMed ID: 32190927)
21. EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin.
Schnell L; Mittler AK; Sadi M; Popoff MR; Schwan C; Aktories K; Mattarei A; Azarnia Tehran D; Montecucco C; Barth H
Toxins (Basel); 2016 Apr; 8(4):101. PubMed ID: 27043629
[TBL] [Abstract][Full Text] [Related]
22. On the Potential Significance of the Intrinsically Disordered Regions in the Clostridiodes difficile Toxins A and B.
El Hadidy N; Uversky VN; Sun X
Curr Protein Pept Sci; 2022 Jul; 23(3):192-209. PubMed ID: 35585826
[TBL] [Abstract][Full Text] [Related]
23. Association between Clostridioides difficile ribotypes, restriction endonuclease analysis types, and toxin gene expression.
Watanabe H; Koizumi Y; Matsumoto A; Asai N; Yamagishi Y; Mikamo H
Anaerobe; 2018 Dec; 54():140-143. PubMed ID: 30201540
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
[TBL] [Abstract][Full Text] [Related]
25.
McKee HK; Kajiwara C; Yamaguchi T; Ishii Y; Shimizu N; Ohara A; Tateda K
J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33830910
[No Abstract] [Full Text] [Related]
26. Use of a neutralizing antibody helps identify structural features critical for binding of
Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
[No Abstract] [Full Text] [Related]
27. Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90.
Kaiser E; Kroll C; Ernst K; Schwan C; Popoff M; Fischer G; Buchner J; Aktories K; Barth H
Infect Immun; 2011 Oct; 79(10):3913-21. PubMed ID: 21768281
[TBL] [Abstract][Full Text] [Related]
28. Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile.
Hinkson PL; Dinardo C; DeCiero D; Klinger JD; Barker RH
Antimicrob Agents Chemother; 2008 Jun; 52(6):2190-5. PubMed ID: 18391047
[TBL] [Abstract][Full Text] [Related]
29. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.
May M; Wang T; Müller M; Genth H
Toxins (Basel); 2013 Jan; 5(1):106-19. PubMed ID: 23344455
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues.
Paparella AS; Aboulache BL; Harijan RK; Potts KS; Tyler PC; Schramm VL
Nat Commun; 2021 Nov; 12(1):6285. PubMed ID: 34725358
[TBL] [Abstract][Full Text] [Related]
31. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins.
Nusrat A; von Eichel-Streiber C; Turner JR; Verkade P; Madara JL; Parkos CA
Infect Immun; 2001 Mar; 69(3):1329-36. PubMed ID: 11179295
[TBL] [Abstract][Full Text] [Related]
32. The Antibiotic Bacitracin Protects Human Intestinal Epithelial Cells and Stem Cell-Derived Intestinal Organoids from
Zhu Z; Schnell L; Müller B; Müller M; Papatheodorou P; Barth H
Stem Cells Int; 2019; 2019():4149762. PubMed ID: 31467562
[TBL] [Abstract][Full Text] [Related]
33. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
[TBL] [Abstract][Full Text] [Related]
34. Effects of Clostridium difficile toxin A and B on human T lymphocyte migration.
Wu D; Joyee AG; Nandagopal S; Lopez M; Ma X; Berry J; Lin F
Toxins (Basel); 2013 May; 5(5):926-38. PubMed ID: 23645153
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Clostridioides difficile DSM 101085 with A-B-CDT+ Phenotype from a Late Recurrent Colonization.
Riedel T; Neumann-Schaal M; Wittmann J; Schober I; Hofmann JD; Lu CW; Dannheim A; Zimmermann O; Lochner M; Groß U; Overmann J
Genome Biol Evol; 2020 May; 12(5):566-577. PubMed ID: 32302381
[TBL] [Abstract][Full Text] [Related]
36. An Update on
Martínez-Meléndez A; Cruz-López F; Morfin-Otero R; Maldonado-Garza HJ; Garza-González E
Toxins (Basel); 2022 Apr; 14(5):. PubMed ID: 35622552
[TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria.
Schwan C; Stecher B; Tzivelekidis T; van Ham M; Rohde M; Hardt WD; Wehland J; Aktories K
PLoS Pathog; 2009 Oct; 5(10):e1000626. PubMed ID: 19834554
[TBL] [Abstract][Full Text] [Related]
38. Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile.
Hartley-Tassell LE; Awad MM; Seib KL; Scarselli M; Savino S; Tiralongo J; Lyras D; Day CJ; Jennings MP
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30530621
[No Abstract] [Full Text] [Related]
39. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
[No Abstract] [Full Text] [Related]
40. Low Density Lipoprotein Receptor-Related Protein-1 (LRP1) Is Involved in the Uptake of
Schöttelndreier D; Langejürgen A; Lindner R; Genth H
Front Cell Infect Microbiol; 2020; 10():565465. PubMed ID: 33194803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
